Expert Pitch
Seattle Children's Hospital

Expert Available to Address Kawasaki Disease in Children with COVID-19

30-Apr-2020 8:20 AM EDT, by Seattle Children's Hospital

Although children don’t typically fall seriously ill from the new coronavirus, doctors in Europe are now expressing concern that children with COVID-19 have developed mysterious symptoms that mimic those appearing with Kawasaki disease.

Dr. Michael Portman, pediatric cardiologist and director of the Kawasaki Disease Clinic at Seattle Children’s Hospital, helps break this emerging issue down for parents and caregivers.

Q: What is Kawasaki disease?

A: Kawasaki disease is an autoimmune response that causes inflammation in arteries. The arteries supplying the heart are particularly susceptible to this inflammation. They can form large sacs called aneurysms, which then can form clots, block blood flow, and cause irreversible and devastating damage to the heart.

Q: Who generally gets Kawasaki disease?

A: Prior to the COVID-19 pandemic, Kawasaki disease affects about 7,000 children in the U.S. each year. It develops during childhood and although it can occur in children of all ages, it most often affects young children under age 5.

Q: What are the symptoms?

A: Diagnosing Kawasaki disease can be challenging because the symptoms – which can include fever, a rash, swollen hands and feet, red eyes, swollen lymph nodes and red, swollen or cracked lips, mouth, throat and tongue – are unspecific and inconsistent. Often the most pronounced symptom is a very high fever between 101 and 104 degrees Fahrenheit that lasts for four or five days.

Q: What should parents do if they see these symptoms in their child?

A: Since the symptoms of Kawasaki disease overlap with those of COVID-19, parents should seek out the advice of a pediatrician for any fever that persists for five days. Although the fever may come and go, it’s important that the child is evaluated promptly by a health care provider familiar with Kawasaki Disease. Evaluation and treatment should not be delayed, especially during the current COVID-19 pandemic.

When treated early in the hospital, most children with Kawasaki disease can fully recover in a matter of days. If left untreated for about 10 or more days, Kawasaki disease can cause serious complications, including life-long aneurysms, stent placement, heart transplant, skin disorders and childhood anxiety. It is the most common cause of acquired permanent heart disease in children.

Q: Why might Kawasaki disease be showing up in children with COVID-19?

A: Kawasaki disease is a puzzling illness, and there is currently no known cause. We believe that a virus or bacteria triggers inflammation and an immune system overreaction. We do not know yet if the coronavirus produces a similar immune response in children. Adults with the coronavirus often show a massive immune response, which is in some ways is similar to that occurring in children with Kawasaki disease. Scattered reports in the media and among Kawasaki disease specialists suggest that some children are showing symptoms of this type of immune response when exposed to the coronavirus.

Q: What are researchers doing to better understand this condition in COVID-19 patients?

A: At Seattle Children’s we are planning studies which will monitor COVID-19 related antibody development in children with Kawasaki-like symptoms. These studies will enable us to understand how a virus triggers the immune response in children with COVID-19, Kawasaki disease or both.

Originally published on Seattle Children's On the Pulse.




Filters close

Showing results

110 of 5575
Released: 6-May-2021 4:20 PM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Newswise

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 6-May-2021 2:15 PM EDT
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

After the Most Comprehensive Review to Date, a Panel of Leading Medical Experts Conclude that Ivermectin Should be Systematically and Globally Adopted for the Prevention and Treatment of COVID-19

Released: 6-May-2021 2:10 PM EDT
儿童同样面临COVID-19的长期影响
Mayo Clinic

COVID-19感染可能对部分儿童和青少年,以及成人的健康产生长期影响。虽然大多数COVID-19儿童感染者症状轻微或根本没有症状,但对于任何COVID-19感染者而言,即使病情轻微或没有症状,感染也可能产生长期影响。

Newswise: CSUCIVaxClinic4-29-21.JPG
Released: 6-May-2021 2:05 PM EDT
CSU Expands Vaccine Availability with New Partnerships
California State University (CSU) Chancellor's Office

Many CSU campuses now offer even more options for students and employees to get their COVID-19 shots, thanks to unique partnerships with national pharmacies and local hospitals.

Released: 6-May-2021 1:50 PM EDT
الأطفال أيضًا يواجهون آثارًا طويلة المدى لفيروس كورونا المستجد (كوفيد-19)
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا ― تؤثر الآثار طويلة المدى لعدوى فيروس كورونا المستجد (كوفيد-19) على صحة بعض الأطفال والمراهقين، وكذا البالغين. في حين أن معظم الأطفال المصابين بعدوى فيروس كورونا المستجد (كوفيد-19) يعانون من أعراض خفيفة أو لا تظهر عليهم أي أعراض على الإطلاق، فإن أي شخص أصيب بفيروس كورونا المستجد (كوفيد-19) - حتى لو كان المرض خفيفًا أو لم تظهر عليه أعراض - قد يُصاب بآثار طويلة المدى.

Released: 6-May-2021 1:35 PM EDT
As crianças também enfrentam efeitos de longo prazo da COVID-19
Mayo Clinic

Os efeitos de longo prazo da infecção por COVID-19 estão afetando a saúde de algumas crianças e adolescentes, bem como de adultos. Embora a maioria das crianças com infecção por COVID-19 tenha sintomas leves ou nenhum sintoma, qualquer pessoa que teve COVID-19, mesmo se leve ou sem sintomas, pode ter efeitos de longo prazo.

Newswise: Retired Nurse Returns to the Front Lines
Released: 6-May-2021 1:25 PM EDT
Retired Nurse Returns to the Front Lines
Rush University Medical Center

During the COVID-19 pandemic, Martha Kuhr, RN, came out of retirement to care for some of Rush University Medical Center's most severe COVID-19 patients in the CVICU.

Released: 6-May-2021 12:40 PM EDT
Achieving high COVID-19 vaccine coverage levels by summer can prevent millions of cases
CUNY Graduate School of Public Health and Health Policy

With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.

Released: 6-May-2021 12:30 PM EDT
Los niños también enfrentan los efectos a largo plazo de la COVID-19
Mayo Clinic

Los efectos a largo plazo de la infección por COVID-19 están repercutiendo en la salud de algunos niños y adolescentes, además de los adultos. Si bien la mayoría de los niños con infección por COVID-19 tienen síntomas leves o no tienen síntomas en absoluto, cualquier persona que haya tenido COVID-19 (incluso si la enfermedad fue leve o no tuvieron síntomas) puede tener efectos a largo plazo.


Showing results

110 of 5575

close
1.71623